Recovery period of COVID-19
Conditions
Interventions
Control group:Basic treatment
Test group:Basic treatment and oral Xiao Chai Hu Tang herbal compound
Sponsors
First Affiliated Hospital of Dalian Medical University
Eligibility
Sex/Gender
All
Age
15 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the discharge criteria in the Novel Coronavirus Pneumonia Treatment Protocol (Trial Version 8) and are under medical observation at the Dalian Rehabilitation Center after discharge; 2. Patients with normal liver and kidney function; 3. Patients who have no history of allergy to Chinese medicine and are willing to take Chinese medicine orally; 4. Patients who can provide voluntary signed informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who were diagnosed with neo-coronavirus pneumonia according to the Novel Coronavirus Pneumonia Treatment Protocol (Trial Version 8) and had not been discharged from the hospital; 2. Patients who had a positive nucleic acid test after discharge; 3. Patients with unstable vital signs and poorly controlled underlying disease; 4. Patients who were allergic to the components of Xiao Chai Hu Tang; 5. Patients who refused to sign the informed consent form for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the depression anxiety stress scales(DASS-21);pittsburgh sleep quality index(PQSI);rating of perceived exertion(RPE);IgG;IgM; | — |
Secondary
| Measure | Time frame |
|---|---|
| hs-CRP;IL-6;CD3+CD8+CD4+ Tcell;NK cell; | — |
Countries
China
Contacts
Public ContactYong Liu
Department of rehabilitation medicine, the First Affiliated Hospital of Dalian Medical University, Dalian, 116011, China
Outcome results
None listed